Deleterious Effect of Radiation Therapy on Epidermodysplasia Verruciformis Patients
Carregando...
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS INC
Autores
Citação
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, v.19, n.4, p.416-421, 2015
Resumo
Background: Epidermodysplasia verruciformis (EV) is a rare genodermatosis caused by specific human papillomavirus (HPV) types associated with the development of multiple squamous cell carcinomas (SCC). The treatment for this skin tumour may be difficult. Among the therapy options, radiotherapy (RT) should be avoided due to its deleterious effects on HPV-induced carcinogenesis. Objective: To describe 4 patients with EV who underwent radiotherapy to treat cutaneous SCC. Methods: This is a retrospective study. The evolution of cutaneous SCC after adjuvant radiotherapy in 4 patients with EV was observed. Results: This study included 4 patients with diagnosis of EV. All 4 of the patients had cutaneous SCC. They underwent surgical resection and adjuvant radiotherapy. Over a period of up to 2 years, there was aggressive tumour recurrence. Conclusion: Radiotherapy might be associated with progression of SCC in patients with EV, and it is recommended that radiotherapy should be avoided in this patient population.
Palavras-chave
epidermodysplasia verruciformis, skin cancer, radiotherapy
Referências
- Berthelot C, 2007, J AM ACAD DERMATOL, V56, P882, DOI 10.1016/j.jaad.2007.01.036
- Gul U, 2007, INT J DERMATOL, V46, P1069, DOI 10.1111/j.1365-4632.2006.03014.x
- Haubner F, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-162
- Jablonska S, 1994, Curr Top Microbiol Immunol, V186, P157
- Janssen Kathleen, 2007, Int J Dermatol, V46 Suppl 3, P45, DOI 10.1111/j.1365-4632.2007.03513.x
- Karrer S, 1999, BRIT J DERMATOL, V140, P935, DOI 10.1046/j.1365-2133.1999.02830.x
- MAJEWSKI S, 1991, J INVEST DERMATOL, V97, P862, DOI 10.1111/1523-1747.ep12491539
- MAJEWSKI S, 1992, AM J MED SCI, V304, P174, DOI 10.1097/00000441-199209000-00006
- MAJEWSKI S, 1995, ARCH DERMATOL, V131, P1312, DOI 10.1001/archderm.131.11.1312
- Majewski S, 2001, HUMAN PAPILLOMAVIRUS, P90
- Oliveira WR, 2006, J EUR ACAD DERMATOL, V20, P1154, DOI 10.1111/j.1468-3083.2006.01654.x
- Oliveira WR, 2004, J AM ACAD DERMATOL, V50, P14
- Oliveira WRP, 2003, J EUR ACAD DERMATOL, V17, P394
- Oliveira WRP, 2003, J DERMATOL, V30, P203
- Oliveira WRP, 2004, J CUTAN MED SURG, V8, P110
- Oliveira WRP, 2004, INT J DERMATOL, V43, P489
- Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008
- Rajabi MT, 2014, CAN J OPHTHALMOL, V49, pE43, DOI 10.1016/j.jcjo.2013.12.009
- Sayhan N, 2001, RES COMMUN MOL PATH, V109, P25